RxDoctor Payments Data

Ronald Feinberg

Reproductive Endocrinology · Newark, DENPI 1689639668

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $12,084 of the $16,225 with a category attached, or 74.5%. 9 manufacturers reported payments, led by Ferring Pharmaceuticals Inc. at 54.3% of the total.

$16,225in general payments, 2019–2025

Across 53 payments — averaging $306.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ferring Pharmaceuticals Inc.$9K
  • IBSA Institut Biochimique SA$7K
  • EMD Serono, Inc.$108
  • AbbVie$102
  • Hologic Sales And Service, LLC$47
  • Merck$37
  • plus $72 from 3 others
$2,486,025in research payments, 2019–2025

Across 100 payments — averaging $24,860 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • IBSA Institut Biochimique SA$1.5M
  • Ferring International Pharmascience Center US$828K
  • Siemens Medical Solutions USA, Inc.$108K

What the payments were for

  • Consulting fees$12,08474%
  • Travel & lodging$2,95718%
  • Food & beverage$1,1847%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few reproductive endocrinology providers in Delawareto place this figure against a meaningful peer group, so we don't.

Other reproductive endocrinology in Newark

Where these figures come from

Is this you, or does something look wrong? →